These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7602438)

  • 1. Residential therapeutic communities in the mainstream: diversity and issues.
    De Leon G
    J Psychoactive Drugs; 1995; 27(1):3-15. PubMed ID: 7602438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The success of therapeutic communities for substance abusers in American prisons.
    Wexler HK
    J Psychoactive Drugs; 1995; 27(1):57-66. PubMed ID: 7602441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incarcerated clients' perceptions of therapeutic change in substance abuse treatment: a 4-year case study.
    Smiley-McDonald HM; Leukefeld CG
    Int J Offender Ther Comp Criminol; 2005 Oct; 49(5):574-89. PubMed ID: 16260484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and treatment outcomes of perceived ward atmosphere among therapeutic community residents.
    Carr WA; Ball SA
    J Subst Abuse Treat; 2014; 46(5):567-73. PubMed ID: 24560437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic communities for addictions: a theoretical framework.
    De Leon G
    Int J Addict; 1995; 30(12):1603-45. PubMed ID: 8557410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "new" drug-free therapeutic community. Challenging encounter of classic and open therapeutic communities.
    Broekaert E; Kooyman M; Ottenberg DJ
    J Subst Abuse Treat; 1998; 15(6):595-7. PubMed ID: 9845873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic communities: diversity in treatment elements.
    Melnick G; De Leon G; Hiller ML; Knight K
    Subst Use Misuse; 2000; 35(12-14):1819-47. PubMed ID: 11138709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the therapeutic community culturally relevant? Findings on race/ethnic differences in retention in treatment.
    De Leon G; Melnick G; Schoket D; Jainchill N
    J Psychoactive Drugs; 1993; 25(1):77-86. PubMed ID: 8483051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saudi addiction therapeutic communities:Are they implementing the essential elements of addiction therapeutic communities.
    Alshomrani AT
    Neurosciences (Riyadh); 2016 Jul; 21(3):227-31. PubMed ID: 27356653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathology and substance abuse: what is being learned from research in therapeutic communities.
    De Leon G
    J Psychoactive Drugs; 1989; 21(2):177-88. PubMed ID: 2668482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise.
    Greenberg B; Hall DH; Sorensen JL
    J Psychoactive Drugs; 2007 Sep; 39(3):203-10. PubMed ID: 18159773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescents in therapeutic communities: one-year posttreatment outcomes.
    Jainchill N; Hawke J; De Leon G; Yagelka J
    J Psychoactive Drugs; 2000; 32(1):81-94. PubMed ID: 10801070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of therapeutic communities: a systematic review.
    Malivert M; Fatséas M; Denis C; Langlois E; Auriacombe M
    Eur Addict Res; 2012; 18(1):1-11. PubMed ID: 21997500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preference for spirituality and twelve-step-oriented approaches among adolescents in a residential therapeutic community.
    Aromin RA; Galanter M; Solhkhah R; Bunt G; Dermatis H
    J Addict Dis; 2006; 25(2):89-96. PubMed ID: 16785224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of therapeutic community for drug dependence in San Francisco (I)].
    Morita N; Nemoto T; Wada K; Suetsugu S; Okasaka Y
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):440-53. PubMed ID: 14639923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing relationship between therapeutic communities and 12-Step programs: a survey.
    Troyer TN; Acampora AP; O'Connor LE; Berry JW
    J Psychoactive Drugs; 1995; 27(2):177-80. PubMed ID: 7562266
    [No Abstract]   [Full Text] [Related]  

  • 17. A therapeutic community for substance-abusing pregnant women and women with children: process and outcome.
    Stevens SJ; Arbiter N
    J Psychoactive Drugs; 1995; 27(1):49-56. PubMed ID: 7602440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental health improvements of substance-dependent clients after 4 months in a Therapeutic Community.
    Polimeni AM; Moore SM; Gruenert S
    Drug Alcohol Rev; 2010 Sep; 29(5):546-50. PubMed ID: 20887579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse treatment options: a federal initiative.
    Arcidiacono A; Saum CA
    J Psychoactive Drugs; 1995; 27(1):105-7. PubMed ID: 7602433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planned duration of residential drug abuse treatment: efficacy versus effectiveness.
    McCusker J; Bigelow C; Vickers-Lahti M; Spotts D; Garfield F; Frost R
    Addiction; 1997 Nov; 92(11):1467-78. PubMed ID: 9519490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.